| Summary of Activities Under Share-Based Compensation Plans |
The following table summarizes the activities for all SARs under the Company’s share-based compensation plans for the year ended December 31, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
Average
Exercise Price
Per Award |
|
Weighted-
Average
Remaining
Contractual
Term |
|
Aggregate
Intrinsic
Value(1) |
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2019(2)(3) |
|
|
|
7,001 |
|
|
|
$ |
27.85 |
|
|
|
|
5.4 years |
|
|
|
$ |
138.7 |
|
| |
|
|
|
— |
|
|
|
$ |
— |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
(3,257 |
) |
|
|
$ |
28.56 |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
(7 |
) |
|
|
$ |
29.03 |
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding as of December 31, 2020(2)(3) |
|
|
|
3,737 |
|
|
|
$ |
27.23 |
|
|
|
|
4.6 years |
|
|
|
$ |
77.8 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable as of December 31, 2020(2)(5) |
|
|
|
3,737 |
|
|
|
$ |
27.23 |
|
|
|
|
4.6 years |
|
|
|
$ |
77.8 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Vested and expected to vest as of December 31, 2020 |
|
|
|
3,737 |
|
|
|
$ |
27.23 |
|
|
|
|
4.6 years |
|
|
|
$ |
77.8 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
The intrinsic value is the amount by which the current market value of the underlying stock exceeds the exercise price of the stock awards. |
| (2) |
Includes less than 0.1 million market condition SARS as of both December 31, 2020 and 2019. |
| (3) |
Includes 1.1 million and 2.9 million performance condition SARs as of December 31, 2020 and 2019, respectively. |
| (4) |
Includes 1.8 million performance condition SARs. |
| (5) |
Includes less than 0.1 million market condition and 1.1 million performance condition SARs. | The following table summarizes the activities for all stock units under the Company’s share-based compensation plans for the year ended December 31, 2020:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-
Average Grant
Date Fair Value
Per Share |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding and nonvested as of December 31, 2019(1) |
|
|
|
1,833 |
|
|
|
$ |
49.49 |
|
| |
|
|
|
1,995 |
|
|
|
$ |
39.67 |
|
| |
|
|
|
(566 |
) |
|
|
$ |
46.53 |
|
| |
|
|
|
(194 |
) |
|
|
$ |
43.79 |
|
| |
|
|
|
|
|
|
|
|
|
|
Outstanding and nonvested as of December 31, 2020(1) |
|
|
|
3,068 |
|
|
|
$ |
44.01 |
|
| |
|
|
|
|
|
|
|
|
|
|
Expected to vest as of December 31, 2020( 5 ) |
|
|
|
2,846 |
|
|
|
$ |
43.66 |
|
| |
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes 712,596 and 475,430 performance based stock unit awards as of December 31, 2020 and 2019, respectively, which represents the maximum amount that can vest. |
| (2) |
Includes 504,908 performance-based stock unit awards. |
| (3) |
Includes 228,996 performance-based stock unit awards. |
(4) |
Includes 38,746 performance-based stock unit awards. |
| (5) |
Includes 561,280 performance-based stock unit awards. |
|